GeoVax Labs, Inc. Announces Six Month 2009 Financial Results and Provides Operational Update

... vaccines for diseases caused by HIV-1 (Human immunodeficiency Virus) and other infectious agents, today ... vaccines for diseases caused by HIV-1 (Human immunodeficiency Virus) and other infectious agents. GeoVax's ... for use in uninfected people to prevent Acquired immunodeficiency Disease (AIDS), caused by the virus known as ...

Immune Deficiency Foundation Honors Cerda Family and Volunteers From ABC's 'Extreme Makeover: Home Edition'

... for their efforts in raising awareness of primary immunodeficiency diseases (PIDD). The family, home builders and ... 250,000 people diagnosed with primary immunodeficiency disease and thousands more go undetected. Primary immunodeficiency diseases occur in patients born with an immune ...

ABC's 'Extreme Makeover: Home Edition' Helps Family Coping with Primary Immunodeficiency Disease

... types of the more than 150 different primary immunodeficiency diseases (PIDD). In the U.S., there are approximately 250,000 people diagnosed with primary immunodeficiency disease and thousands more go undetected. ... and quality of life of persons with primary immunodeficiency diseases through advocacy, education, and ...

Aethlon Medical Discloses New HIV/AIDS Treatment Data

... of the Aethlon Hemopurifier(R) to treat Human immunodeficiency Virus (HIV), the disease that causes Acquired ... load in both Hepatitis-C Virus (HCV) and Human immunodeficiency Virus (HIV) infections. As a result, Aethlon ... progression of Hepatitis-C Virus (HCV) and Human immunodeficiency Virus (HIV), and serves as a broad-spectrum ...

CIDP Treated With Plasma-Derived Therapy

... sites of care and to complete the hollow primary immunodeficiency disease (PIDD) home infusion benefit. If passed, ... hemophilia and other bleeding disorders, primary immunodeficiency diseases, alpha-1 antitrypsin deficiency, ... about CIDP. For information about primary immunodeficiency disease, visit www.primaryimmune.org . ...

New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin

... and life-enhancing therapy for many primary immunodeficiency diseases; chronic lymphocytic leukemia; Kawasaki ... therapy to help them live with their primary immunodeficiency disease, neurological, autoimmune or other rare ... with her two young daughters, battles combined immunodeficiency disease and whose family will be featured on the ...

Yerkes researchers propose ambitious new strategies for AIDS vaccine research

... in the development of an effective AIDS vaccine. Based on studying simian immunodeficiency viruses (SIVs) in African nonhuman primates, they propose an additional ... nonhuman primate species and represent the original source of human immunodeficiency viruses (HIV-1 and HIV-2). More than 40 species of African monkeys are ...

Aethlon Medical Confirms Hemopurifier(R) Is a Treatment Candidate Against Swine Flu Virus

... in reducing patient viral load in both Hepatitis-C Virus (HCV) and Human immunodeficiency Virus (HIV) infections. As a result, Aethlon believes the Hemopurifier(R) ... to inhibit disease progression of Hepatitis-C Virus (HCV) and Human immunodeficiency Virus (HIV), and serves as a broad-spectrum treatment countermeasure ...

New Roche Dual Target HIV-1 Test Approved for Use in European Union

... 2.1 million died of AIDS, including 330,000 children. The human immunodeficiency virus (HIV) is a retrovirus that infects cells of the human immune system, ... symptoms. Within 10-15 years an HIV infection will develop into acquired immunodeficiency syndrome (AIDS); antiretroviral drugs can slow down this process even ...

Do antidepressants enhance immune function?

... Philadelphia, PA, May 8, 2008 Infection with human immunodeficiency virus (HIV), which leads to acquired immunodeficiency syndrome (AIDS), is an epidemic of global concern. According to the most ...

Wisconsin First State in Nation to Screen Newborns for 'Bubble Boy Disease'

... Modell in memory of their son Jeffrey who died at age 15 from a Primary immunodeficiency (PI). SCID is one of 140 PI diseases. The pilot, which continues through ... in memory of their son, Jeffrey, who died from complications of Primary immunodeficiency at the age of 15. JMF is a multi-faceted global nonprofit foundation ...

GeoVax Co-Founder Dr. Harriet Robinson Named 2007 AAAS Fellow

... and commercialize human vaccines for diseases caused by HIV-1 (Human immunodeficiency Virus) and other infectious agents. GeoVax's vaccine technology is ... GeoVax HIV/AIDS vaccines are designed to prevent development of Acquired immunodeficiency Disease (AIDS), caused by the virus known as HIV-1, by vaccinating ...

Domestic cat genome sequenced

... excellent model for human infectious diseases, including HIV/AIDS. Feline immunodeficiency virus (FIV) is a genetic relative of human immunodeficiency virus (HIV), which causes AIDS. Using the cat genome sequence data, the ...

Cat's Genome Map Purrfected

... that affect humans, such as HIV/AIDS. Cats can be infected by feline immunodeficiency virus (FIV), which is a genetic relative of human immunodeficiency virus (HIV), which causes AIDS. A report detailing the sequencing of ...

Reunion with patient inspires follow-up study on treatment for DiGeorge syndrome

... serve as a thymus equivalent." DiGeorge syndrome is a common genetic immunodeficiency that occurs in one out of every 2,000 people. The syndrome includes thymic ... characteristic of complete DGS, which is similar to severe combined immunodeficiency (also known as "bubble boy syndrome") and is fatal if untreated. In this ...

Progression of SIV infection in monkeys raises

... study, Acute Loss of Intestinal CD4+ T Cells is Not Predictive of Simian immunodeficiency Virus Virulence, challenges current thinking regarding AIDS, namely that a ... to full-blown AIDS in humans, some non-human primates infected with simian immunodeficiency virus (SIV) do not develop AIDS after such a depletion. African green ...

Federal Judge Sentences Defendants Who Perpetrated $10.9 Million Medicare Fraud HIV Infusion Scheme

... Group of South Florida Inc. (M&P Group) and Tendercare Medical Center Inc. (Tendercare), which purported to specialize in the treatment of Human immunodeficiency Virus (HIV). Russell was the medical director for both M&P Group and Tendercare during their operations. Pacheco and Milanes worked as ...

VivaGel(R) Demonstrates Anti-HIV and Herpes Activity Following Human Administration

... (ASX: SPL, OTCQX: SPHRY) today announced the results of its clinical trial demonstrating that VivaGel(R) retains antiviral activity against human immunodeficiency virus (HIV) and herpes simplex virus (HSV, the virus that causes genital herpes), following vaginal administration in women. The clinical ...

96-Week Safety and Efficacy Findings Presented for INTELENCE(TM) (etravirine) As Part of HIV Combination Therapy

... data from DUET-1 and DUET-2. INTELENCE, in combination with other antiretroviral (ARV) agents, is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains ...

New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U.S. HIV Clinical Studies

... Adults PREZISTA, co-administered with ritonavir (PREZISTA/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (HIV-1) infection. This indication is based on analyses of plasma HIV RNA levels and CD4+ cell counts from 2 controlled Phase 3 ...

Pharmasset Nominates PSI-938 as a New Nucleotide Analog Inhibitor of Hepatitis C for Preclinical Development

... of oral therapeutics for the treatment of hepatitis C virus (HCV) and, secondarily, on the development of Racivir(R) for the treatment of human immunodeficiency virus (HIV). Our research and development efforts focus on nucleos(t)ide analogs, a class of compounds which act to inhibit the enzymes required for ...

WVU Doctor Works to Reduce Cancer Burden in Africa

... infectious agents -- even though they constitute a significant burden." Transmissible causes include viruses such as Epstein-Barr virus, human immunodeficiency virus (HIV), Hepatitis B and Hepatitis C viruses, and the human papillomavirus. Viruses may hit the developing world particularly hard, but rising ...

Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-7851 in Chronic Hepatitis C Patients

... of oral therapeutics for the treatment of hepatitis C virus (HCV) and, secondarily, on the development of Racivir(R) for the treatment of human immunodeficiency virus (HIV). Our research and development efforts focus on nucleos(t)ide analogs, a class of compounds which act to inhibit the enzymes required for ...

American Academy of Dermatology Issues New Guidelines For the Management of Psoriasis With Systemic Medications

... to conceive. In addition, methotrexate should not be prescribed to nursing mothers, those with chronic liver disease, alcoholics, or patients with immunodeficiency syndromes, among others. Cyclosporine Cyclosporine is one of the most effective treatments for psoriasis and induces immunosuppresion by ...

Sales of Antiretroviral Agents Will Drive Substantial Six Percent Annual Growth in the HIV Drug Market Through 2013

... from 2013 to 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. The new Pharmacor report entitled Human immunodeficiency Virus finds that continued increase in the uptake of Bristol-Myers Squibb/Gilead's Atripla will drive the agent to garner the highest sales of any ...

Vaccine Shields Monkeys From Simian Form of HIV

... for the development of an AIDS vaccine that might actually work, researchers report they were able to protect monkeys against infection with simian immunodeficiency virus (SIV), the primate version of HIV. They did so by using a novel approach that delivered antibody-producing genes directly to the animals' ...

Pharmasset to Present at Deutsche Bank Healthcare Conference

... of oral therapeutics for the treatment of hepatitis C virus (HCV) and, secondarily, on the development of Racivir(R) for the treatment of human immunodeficiency virus (HIV). Our research and development efforts focus on nucleos(t)ide analogs, a class of compounds which act to inhibit the enzymes required for ...

Vietnam Veterans of America Calls for Openness and Transparency in Addressing Contaminated Medical Equipment at VAMCs

... Rowan said. According to a VA press release dated April 3rd, 17 veterans had tested positive for hepatitis B, hepatitis C, or the Human immunodeficiency (HIV) Virus. Eleven of these were tested at the VA's Murfreesboro Medical Center; the other six were tested at the Augusta hospital. That was the ...

Aethlon Medical Announces Engagement of RedChip Companies to Initiate Investor and Media Relations Programs

... immunosuppressive particles from the human circulatory system. The device targets to inhibit disease progression of Hepatitis-C Virus (HCV) and Human immunodeficiency Virus (HIV), and serves as a broad-spectrum treatment countermeasure against bioterror and emerging pandemic threats. The Hemopurifier(R) also holds ...

Aethlon Medical Announces CEO Interview and Corporate Presentation Available Online

... immunosuppressive particles from the human circulatory system. The device targets to inhibit disease progression of Hepatitis-C Virus (HCV) and Human immunodeficiency Virus (HIV), and serves as a broad-spectrum treatment countermeasure against bioterror and emerging pandemic threats. The Hemopurifier(R) also holds ...

VA Continues Notification Process for Veterans Affected by Reprocessing Issues

... Miami hospital from May 2004 to March 2009. As of April 1, 2009, 17 Veterans have tested positive for Hepatitis B, Hepatitis C, or the Human immunodeficiency (HIV) Virus. Five Veterans tested positive for Hepatitis B virus; eleven for Hepatitis C; and one for HIV. Of the positive test results, eleven were ...

New HIV Drug May Help Those Resistant to Therapy

... In the study, researchers tested the effectiveness of a molecule called D-1mT and anti-retroviral therapy (ART) in macaque monkeys with simian immunodeficiency virus (SIV), which is similar to HIV in humans. After six days of treatment, only three of the macaques had detectable SIV levels, and after 13 days, ...

Pharmasset to Present at Two Upcoming Investor Conferences

... Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Pharmasset is currently developing four product candidates. Clevudine, for the treatment of chronic HBV infection, is enrolling ...

Keystone Symposia to Mark 25th Anniversary of its First HIV/AIDS Meeting

... by Dr. Francoise Barre-Sinoussi, the 2008 Nobel Laureate in Medicine. In the mid-80s, Barre-Sinoussi co-discovered the virus that causes AIDS - Human immunodeficiency Virus (HIV) - along with colleague Dr. Luc Montagnier. Barre-Sinoussi is Head of the Retroviral Infection Control Unit at Institut Pasteur in Paris ...

Jury Convicts Two Doctors and Two Medical Assistants in $5.3 Million Medicare Fraud Scam

... clinics, Medcore Group LLC (Medcore) and M&P Group of South Florida Inc. (M&P Group), that purported to specialize in the treatment of human immunodeficiency virus (HIV). Evidence at trial established that Rothman was the medical director for both Medcore and M&P Group between May 2004 and January ....

Pharmasset to Present at Two Upcoming Investor Conferences

... Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Pharmasset is currently developing four product candidates. Clevudine, for the treatment of chronic HBV infection, is enrolling ...

OHSU vaccine research targets HIV in the slower, early stage of infection

... the spread of the virus." To determine whether they could proactively "educate" the immune system, scientists used a monkey model of AIDS - simian immunodeficiency virus (SIV) the monkey counterpart to HIV. They introduced an altered monkey form of cytomegalovirus (CMV) programmed to express SIV proteins and ...

IMPACT Study Demonstrates That Longer Prophylactic Therapy With Valcyte(R) (Valganciclovir Hydrochloride Tablets) Increases Protection Against CMV - the Most Serious Viral Infection Affecting Transplant Patients

... acute rejection and graft loss. About Valcyte Valcyte tablets are indicated for the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS). Valcyte is indicated for the prevention of CMV disease in kidney, heart, and kidney-pancreas transplant patients at high risk. ...

Tibotec Submits Application to U.S. Food and Drug Administration Seeking Traditional Approval for INTELENCE(TM) (etravirine)

... approval for INTELENCE. INTELENCE, in combination with other antiretroviral agents, is currently indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment-experienced adult patients, who have evidence of viral replication and HIV-1 strains ...

UCSF Finds Potential New Antibody Treatment for Autoimmune Diseases

... suggested a defect in the patient's immune system similar to Acquired Immune Deficiency Syndrome (AIDS), but the patient tested negative for human immunodeficiency virus (HIV). Further studies revealed that the patient's CD4 T cells did not move out of her lymph nodes as they would in a normal immune system ...